Sfoglia per RIVISTA
BLOOD ADVANCES
Collezione AOU Città della Salute di Torino

  

Items : 29

Safety Run-In and Part 1 of GIMEMA AML1718: Venetoclax Combined with FLAI as Induction Treatment in Non-Low-Risk AML. in Blood advances / Blood Adv. 2025 Mar 6:bloodadvances.2024014901. doi: 10.1182/bloodadvances.2024014901.

2025
AOU Città della Salute di Torino

Marconi G; Piciocchi A; Audisio E; Papayannidis C; Cerrano M; Minotti C; Paoloni F; Guolo F; Bocchia M; Rondoni M; Lico A; Carrabba MG; Della Porta MG; Frigeni M; Giaccone L; Beltrami G; Cattaneo C; Di Chio MC; Serio B; Crea E; Freilone R; Capria S; Curti A; Minetto P; la Sala E; Nanni J; Zannetti BA; Simonetti G; Bochicchio MT; et alii...

Prognostic role of interim PET in patients with follicular lymphoma: a post-hoc study of FOLL12 trial by FIL. in Blood advances / Blood Adv. 2025 Mar 19:bloodadvances.2024014790. doi: 10.1182/bloodadvances.2024014790.

2025
AOU Città della Salute di Torino

Durmo R; Chauvie S; Fallanca F; Bergesio F; Pinto A; Del Giudice I; Coscia M; Corradini P; Angelucci E; Tosi P; Freilone R; Ballerini F; Bari A; Pastore D; Zinzani PLL; Bolis SAM; Flenghi L; Liso A; Olivieri J; Marcheselli L; Merli M; Versari A; Guerra L; Luminari S;

COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody? in Blood advances / Blood Adv. 2025 Jan 14;9(1):162-165. doi: 10.1182/bloodadvances.2024013792.

2025
AOU Città della Salute di Torino

Autore F; Visentin A; Deodato M; Vitale C; Galli E; Fresa A; Fazzi R; Sanna A; Olivieri J; Scortechini I; Del Principe MI; Sportoletti P; Innocenti I; Coscia M; Tedeschi A; Trentin L; Candoni A; Busca A; Pagano L; Laurenti L;

Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial. in Blood advances / Blood Adv. 2025 Jan 14:bloodadvances.2024014948. doi: 10.1182/bloodadvances.2024014948.

2025
AOU Alessandria
AOU Città della Salute di Torino

da Silva MG; Zilioli VRR; Balzarotti M MD; Boccomini C; Postorino M; Merli M; Careddu MG; Lucchini E; Patti C; Palmas AD; Pascarella A; Michieli M; Vallisa D; Puccini B; Ballerini F; Stefoni V Dr; Cavallo F; Amaducci E; Evangelista A; Civita AM; Alessandria B; Gandossini M; Genuardi E; Ragaini S; Galli A; Bruno B; Rizzo E; Ladetto M; Malcovati L; et alii...

Post Transplant Cyclophosphamide as GvHD Prophylaxis in Patients Receiving Mismatched Unrelated HCT: the PHYLOS trial. in Blood advances / Blood Adv. 2025 Feb 10:bloodadvances.2024015173. doi: 10.1182/bloodadvances.2024015173.

2025
AOU Città della Salute di Torino

Raiola A; Bruno B; Risitano AM; Mosna F Dr; Cavattoni IM; Onida F; Saporiti GN; Patriarca F; Battista ML; Pavone V; Mele A MD; Chiusolo P; Sica S; Loteta B; di Grazia C; Carella AM; Salvatore D; Morello E; Leoni A; Giaccone L; Bernasconi P; Terruzzi E; Mordini N; Borghero C; Zallio F; Luppi M; Grassi A; Olivieri A; Piras E; et alii...

Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission. in Blood advances / Blood Adv. 2024 May 28;8(10):2405-2409. doi: 10.1182/bloodadvances.2023012139.

2024
AOU Città della Salute di Torino

Urbino I; Lengliné E; Rabian F; Cerrano M; Kim R; Chevillon F; Ferrero D; Sébert M; Dhédin N; Itzykson R; Adès L; Raffoux E; Dombret H; Audisio E; Clappier E; Boissel N;

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
AOU Alessandria
AOU Città della Salute di Torino

Dore F; Pinotti G; Pisani F; Ghiggi C; Zanni M; Annibali O; Liberati AM; Celli M; Cabras MG; Orsucci L; Bruna R; Tani M; Vanazzi A; Tucci A; Merli F; Balzarotti M; Gaidano G; Sassone M; Botto B; Stathis A; Ferreri AJM; Chiappella A; Conconi A; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Vitolo U; Zucca E; et alii...

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib. in Blood advances / Blood Adv. 2023 Jun 27;7(12):2794-2806. doi: 10.1182/bloodadvances.2022008821.

2023
AOU Città della Salute di Torino

Bonfiglio S; Sutton LA; Ljungström V; Capasso A; Pandzic T; Weström S; Foroughi-Asl H; Skaftason A; Gellerbring A; Lyander A; Gandini F; Gaidano G; Trentin L; Bonello L; Reda G; Bödör C; Stavroyianni N; Tam CS; Marasca R; Forconi F; Panayiotidis P; Ringshausen I; Jaksic O; Frustaci AM; Iyengar S; Coscia M; Mulligan SP; Ysebaert L; Strugov V; et alii...

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial. in Blood advances / Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504.

2023
AOU Alessandria
AOU Città della Salute di Torino

Puccini B; Ferreri AJM; Ballerini F; Lucchini E; Arcaini L; Moita F; Zilioli V; Balzarotti M; Cavallo F; Boccomini C; Stefoni V; Re A; Di Rocco A; Tavarozzi R; Ghislieri M; De Luca G; Genuardi E; Alessandria B; Zaccaria GM; Pironti M; Arrigoni E; Grimaldi D; Ferrero S; Palumbo GA; Galimberti S; Cortelazzo S; Di Paolo A; Ladetto M;

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL. in Blood advances / Blood Adv. 2023 Aug 8;7(15):3916-3924. doi: 10.1182/bloodadvances.2023009744.

2023
AOU Alessandria
AOU Città della Salute di Torino

Stelitano C; Quaglia FM; Pileri SA; Ferrante M; Bruna R; Sciarra R; Zanni M; Zambello R; Chini C; Ghiggi C; Di Rocco A; Cencini E; Puccini B; Celli M; Tani M; Botto B; Spina M; Ferrero S; Evangelista A; Patti C; Moia R; Tisi MC; Re A; Volpetti S; Zilioli VR; Arcari A; Merli F; Visco C;

A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2023 Aug 8;7(15):4160-4169. doi: 10.1182/bloodadvances.2023009839.

2023
AOU Alessandria
AOU Città della Salute di Torino

Cencini E; Ferrero S; Dessì D; Nassi L; Pagani C; Vallisa D; Merli M; Tani M; Di Rocco A; Flenghi L; Tarantini G; Hohaus S; Zanni M; Gini G; Botto B; Sartori R; Marino D; Musuraca G; Mahmoud AM; Zilioli VR; Pennese E; Luminari S; Pelliccia S; Balzarotti M; Fabbri A; Cavallo F; Usai SV; Puccini B; Tucci A; et alii...

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial. in Blood advances / Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596.

2023
AOU Città della Salute di Torino

Bassan R; Chiaretti S; Della Starza I; Spinelli O; Santoro A; Paoloni F; Messina M; Elia L; De Propris MS; Scattolin AM; Audisio E; Marbello L; Borlenghi E; Zappasodi P; Mauro E; Martinelli G; Mattei D; Fracchiolla N; Bocchia M; De Fabritiis P; Bonifacio M; Candoni A; Cassibba V; Di Bartolomeo P; Latte G; Trappolini S; Guarini A; Vitale A; Fazi P; et alii...

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma. in Blood advances / Blood Adv. 2022 Nov 22;6(22):5811-5820. doi: 10.1182/bloodadvances.2022007475.

2022
AOU Città della Salute di Torino

Ferreri AJM; Angelillo P; Erbella F; Cattaneo C; Verga L; Lleshi A; Allione B; Ponzoni M; Facchetti F; Pagani C; Foppoli M; Pecciarini L; Sassone M; Steffanoni S; Flospergher E; Rossi G; Spina M; Re A;

COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey. in Blood advances / Blood Adv. 2022 Jul 12;6(13):3870-3874. doi: 10.1182/bloodadvances.2022007357.

2022
AOU Alessandria
AOU Città della Salute di Torino

Passamonti F; Pagliuca A; Koehler P; Klimko N; Corradini P; Hoenigl M; Busca A; Zompi S; Sacchi MV; Nunes Rodrigues R; Nordlander A; Essame J; Cordoba R; Batini? J; Bergantim R; Bilgin YM; Blennow O; Cattaneo C; Duarte RF; Emarah Z; Gomes da Silva M; González-López TJ; Kulasekararaj A; Ledoux MP; López-García A; Merelli M; Prezioso L; Ilhan O; Seval GC; et alii...

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. in Blood advances / Blood Adv. 2022 Jul 12;6(13):3875-3878. doi: 10.1182/bloodadvances.2022006964.

2022
AOU Alessandria
AOU Città della Salute di Torino

Trentin L; Angeletti I; Coscia M; Patti C; Sanna A; Murru R; Sapienza G; Cuccaro A; Marasca R; Sportoletti P; Morelli F; Chiarenza A; Vitale C; Moretti M; Tomasso A; Visentin A; Catania G; Piciocchi A; Autore F; Fresa A; Pietrasanta D; Innocenti I; Laurenti L;

An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia. in Blood advances / Blood Adv. 2022 Jan 11;6(1):87-99. doi: 10.1182/bloodadvances.2021004878.

2022
AOU Città della Salute di Torino

Ragaini S; Wagner S; Marconi G; Parisi S; Sartor C; Nanni J; Cristiano G; Talami A; Olivi M; Ocadlikova D; Ciciarello M; Corradi G; Ottaviani E; Papayannidis C; Paolini S; Vadakekolathu J; Cavo M; Rutella S; Curti A;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Merli F; Krampera M; Corradini P; Passamonti F; Lanza F; Candoni A; Conconi A; Tosi P; Vallisa D; Venditti A; Selleri C; La Barbera EO; Gambacorti-Passerini C; Visani G; Rigacci L; Armiento D; Cilloni D; Corso A; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Cardinali V; Turrini M; Trentin L; Della Porta M; Scattolin A; Tisi MC; Cuneo A; et alii...

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. in Blood advances / Blood Adv. 2022 Apr 12;6(7):2427-2433. doi: 10.1182/bloodadvances.2021005616.

2022
AOU Città della Salute di Torino

Busca A; Salmanton-García J; Corradini P; Marchesi F; Cabirta A; Di Blasi R; Dulery R; Lamure S; Farina F; Weinbergerová B; Batini? J; Nordlander A; López-García A; Drgo?a ?; Espigado-Tocino I; Falces-Romero I; García-Sanz R; García-Vidal C; Guidetti A; Khanna N; Kulasekararaj A; Maertens J; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Cornely OA; Pagano L; et alii...

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4370-4379. doi: 10.1182/bloodadvances.2021004649.

2021
AOU Città della Salute di Torino

Efficace F; Platzbecker U; Breccia M; Cottone F; Carluccio P; Salutari P; Di Bona E; Borlenghi E; Autore F; Levato L; Finizio O; Mancini V; D'Ardia S; Schlenk RF; Melillo L; Fumagalli M; Fiedler W; Beltrami G; Fracchiolla NS; Bernardi M; Fazi P; Annibali O; Mayer K; Voso MT; Vignetti M;

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4504-4514. doi: 10.1182/bloodadvances.2021005150.

2021
AOU Alessandria
AOU Città della Salute di Torino

Botto B; Abruzzese E; Zaja F; Tani M; Simontacchi G; Rigacci L; Santoro A; Grapulin L; Pulsoni A; Frezza GP; Franzone P; Zanni M; Nassi L; Nardella A; Pavone V; Re A; Buglione M; Gotti M; Gioia DM; Sacchetti GM; Evangelista A; Levis M; Ricardi U; Zilioli VR; Rota-Scalabrini D; Freilone R; Ciccone G; Filippi AR; Zinzani PL; et alii...

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project. in Blood advances / Blood Adv. 2021 Feb 9;5(3):640-648. doi: 10.1182/bloodadvances.2020001581.

2021
AOU Città della Salute di Torino

Shustov A; Cabrera ME; Civallero M; Bellei M; Ko YH; Manni M; Skrypets T; Horwitz SM; De Souza CA; Radford JA; Bobillo S; Prates MV; Ferreri AJM; Chiattone C; Spina M; Vose JM; Chiappella A; Laszlo D; Marino D; Stelitano C; Federico M;

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib? in Blood advances / Blood Adv. 2021 Dec 28;5(24):5490-5500. doi: 10.1182/bloodadvances.2021004824.

2021
AOU Città della Salute di Torino

Tedeschi A; Frustaci AM; Mauro FR; Chiarenza A; Coscia M; Ciolli S; Reda G; Laurenti L; Varettoni M; Murru R; Baratè C; Sportoletti P; Greco A; Borella C; Rossi V; Deodato M; Biagi A; Zamprogna G; Pelle AC; Lapietra G; Vitale C; Morelli F; Cassin R; Fresa A; Cavalloni C; Postorino M; Ielo C; Cairoli R; Di Raimondo F; et alii...

Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE). in Blood advances / Blood Adv. 2020 Oct 13;4(19):4632-4639. doi: 10.1182/bloodadvances.2020002637.

2020
AOU Città della Salute di Torino

Thom K; Lensing AWA; Nurmeev I; Bajolle F; Bonnet D; Kenet G; Massicotte MP; Karakas Z; Palumbo JS; Saracco P; Amedro P; Chain J; Chan AK; Ikeyama T; Lam JCM; Gauger C; Pap ÁF; Majumder M; Kubitza D; Smith WT; Berkowitz SD; Prins MH; Monagle P; Young G; Male C;

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma. in Blood advances / Blood Adv. 2020 Nov 10;4(21):5449-5459. doi: 10.1182/bloodadvances.2020001965.

2020
AOU Città della Salute di Torino

Facon T; Niesvizky R; Mateos MV; Siegel D; Rosenbaum C; Bringhen S; Weisel K; Ho PJ; Ludwig H; Kumar S; Wang K; Obreja M; Yang Z; Klippel Z; Mezzi K; Goldrick A; Tekle C; Dimopoulos MA;

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT). in Blood advances / Blood Adv. 2020 Dec 22;4(24):6250-6258. doi: 10.1182/bloodadvances.2020003244.

2020
AOU Città della Salute di Torino

Connor P; Sánchez van Kammen M; Lensing AWA; Chalmers E; Kállay K; Hege K; Simioni P; Biss T; Bajolle F; Bonnet D; Grunt S; Kumar R; Lvova O; Bhat R; Van Damme A; Palumbo J; Santamaria A; Saracco P; Payne J; Baird S; Godder K; Labarque V; Male C; Martinelli I; Morales Soto M; Motwani J; Shah S; Hooimeijer HL; Prins MH; et alii...

Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy. in Blood advances / Blood Adv. 2020 Aug 25;4(16):3900-3912. doi: 10.1182/bloodadvances.2020001620.

2020
AOU Città della Salute di Torino

Mariotti J; Raiola AM; Evangelista A; Carella AM; Martino M; Patriarca F; Risitano A; Bramanti S; Busca A; Giaccone L; Brunello L; Merla E; Savino L; Loteta B; Console G; Fanin R; Sperotto A; Marano L; Marotta S; Frieri C; Sica S; Chiusolo P; Harbi S; Furst S; Santoro A; Bacigalupo A; Blaise D; Angelucci E; Mavilio D; et alii...

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Alessandria
AOU Città della Salute di Torino

Rupoli S; Rege-Cambrin G; Rapezzi D; Pregno P; Palmieri F; Musolino C; Montefusco E; Melpignano A; Miggiano MC; Martino B; Marasca R; Malagola M; Lunghi M; Lunghi F; Luciano L; Lucchesi A; Levato L; La Barba G; Iurlo A; Gozzini A; Gugliotta G; Giai V; Galimberti S; Fozza C; Fazi P; Fava C; Elena C; D'Adda M; Crugnola M; et alii...

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. in Blood advances / Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625.

2019
AOU Alessandria
AOU Città della Salute di Torino

Spinelli O; Oldani E; Zanghì P; Ferrero D; Cortelezzi A; Corradini P; Campiotti L; Todisco E; Scattolin AM; Bernardi M; Borlenghi E; Ciceri F; Cattaneo C; De Paoli L; Terruzzi E; Mattei D; Cavattoni I; Marmont F; Gianfaldoni G; Boschini C; Pavoni C; Masciulli A; Bassan R; Intermesoli T; Audisio E; Cortelazzo S; Bosi A; Falini B; Pogliani EM; et alii...

Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment. in Blood advances / Blood Adv. 2016 Nov 22;1(1):47-61. doi: 10.1182/bloodadvances.2016000984. eCollection 2016 Nov 29.

2016
AOU Città della Salute di Torino

Serra S; Vaisitti T; Audrito V; Bologna C; Buonincontri R; Chen SS; Arruga F; Brusa D; Coscia M; Jaksic O; Inghirami G; Rossi D; Furman RR; Robson SC; Gaidano G; Chiorazzi N; Deaglio S;